|Merrimack Pharmaceuticals Inc -- USA Stock|| |
USD 10.18 0.17 1.64%
Chief Scientific Officer and Sr. VP of Research
Dr. Ulrik B. Nielsen, Ph.D., is Director of Company. He has served as a member of our board of directors since January 2015 and is one of our cofounders. Dr. Nielsen led our research and drug discovery from when he joined us in 2002 to January 2015, including as our Senior Vice President and Chief Scientific Officer from March 2009 until January 2015. Dr. Nielsen has served as President and Chief Executive Officer of Torque Inc., a biotechnology company, since January 2015. Dr. Nielsen also served as Chief Executive Officer of Silver Creek Pharmaceuticals, Inc., a majority owned subsidiary of ours, from July 2010 to March 2014
Age: 43 SVP Since 2015
617 441-1000 www.merrimack.com
Nielsen holds a Ph.D. in molecular biology and an M.S. in biochemistry from the University of Copenhagen.
The company has return on total asset (ROA)
of (29.74) %
which means that it has lost $29.74 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (19.0) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 49.88 M in liabilities with Debt to Equity (D/E) ratio of 44.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Merrimack Pharmaceuticals Inc has Current Ratio of 3.28 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer primarily in the United States. Merrimack Pharmaceuticals Inc (MACK) is traded on NASDAQ General Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 426 people. Merrimack Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.